Previously submitted to: JMIR Research Protocols (no longer under consideration since Oct 19, 2022)
Date Submitted: Oct 9, 2022
Open Peer Review Period: Sep 24, 2022 - Oct 19, 2022
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
The effect of mHealth interventions on obstetrics and gynecologic health outcomes: a protocol for a systematic review of randomized controlled trials
ABSTRACT
Background:
The issue of women's health as a high-risk group has been declared by the World Health Organization as a primary priority for all human societies. In the meantime, mHealth has provided countless opportunities to reduce health inequalities, increase access to care and provide innovative interventions for women, leading to various interventions in this field. The need to check the effectiveness of these interventions seems to be an inevitable necessity. Previous systematic review articles have not comprehensively examined all types of mHealth interventions in obstetrics and gynecology.
Objective:
Our study aims to review and analyze the evidence from randomized clinical trials to comprehensively investigate the role of accompanying health in the outcomes related to women's health related to gynecological and obstetric diseases.
Methods:
We will conduct a systematic review that includes randomized controlled trials examining the effectiveness of mHealth interventions in obstetrics and gynecology. The search strategy will include "mHealth," "obstetrics and gynecology," and " Randomized controlled trials " and their synonyms. We will search Scopus, Springer, ScienceDirect, PubMed/MEDLINE, ClinicalTrials.gov, Cochrane Library, and Cochrane Collaboration Registry of Controlled Trials to identify trials published in English from 2010 to December 2021. MHealth is described as all healthcare services provided by mobile phone technology, tablets, laptops, PDAs, and other wearable and portable devices. Two authors independently screened articles based on inclusion and exclusion criteria, assessed the risk of bias, and extracted data. Data will be tabulated and grouped for narrative synthesis for comparison between studies. We will assess the quality of evidence for the primary outcomes using GRADE.
Results:
The findings will be disseminated through publication in a peer-reviewed journal.
Conclusions:
The findings will be disseminated through publication in a peer-reviewed journal. Clinical Trial: Prospero registration number: CRD42021261478.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.